Irini Lambiri

Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers.

Gernot Keyszer, Irini Lambiri, Rollin Nagel et al. · PubMed · 1999 · 160 citations

Evaluation of health-related quality-of-life and dyspnea scales in patients with idiopathic pulmonary fibrosis. Correlation with pulmonary function tests

Νikolaos Tzanakis, Irini Lambiri, Nikolaos M. Siafakas et al. · European Journal of Internal Medicine · 2005 · 84 citations

Pulmonary Function Tests, Quality Of Life, Advanced Lung Disease +9

Effects of antifibrotic agents on TGF-β1, CTGF and IFN-γ expression in patients with idiopathic pulmonary fibrosis

Eleni Tzortzaki, Maria I. Zervou, Irini Lambiri et al. · Respiratory Medicine · 2007 · 40 citations · Full text

Inflammation, Fibrosis, Antifibrotic Therapy +13

Matrix metalloproteinases, but not cathepsins B, H, and L or their inhibitors in peripheral blood of patients with rheumatoid arthritis are potentially useful markers of disease activity

Gernot Keyszer, Irini Lambiri, M Keysser et al. · Zeitschrift für Rheumatologie · 1998 · 34 citations

Inflammation, Rheumatology, Rheumatoid Disorder +11

Active Remodeling in Idiopathic Interstitial Pneumonias: Evaluation of Collagen Types XII and XIV

Eleni Tzortzaki, Anastassios V. Koutsopoulos, Konstantina I. Dambaki et al. · Journal of Histochemistry & Cytochemistry · 2006 · 25 citations · Full text

Inflammation, Fibrosis, Advanced Lung Disease +15